Skip to Main Content

Paper Details

FGFR2 Inhibition in Cholangiocarcinoma.
Annu Rev Med
13
2023
Author NameAffiliation
Arndt VogelHannover Medical School
Arndt VogelCenter for Personalized Medicine (ZPM), Hannover Medical School
Albrecht StenzingerInstitute of Pathology, University Hospital Heidelberg
  • 1 - 3

Datasets

Release 1.2